Clinical Trials List
2023-11-16 - 2027-01-31
Phase III
Not yet recruiting1
Recruiting4
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chiun Hsu 無
- YU-YUN SHAO 無
- 莊建淮 無
- 林宗哲 無
- 呂理駿 無
- Ta-Ching Chen Division of Ophthalmology
- Ann-Lii Cheng 無
- Ying-Chun Shen 無
- TSUNG-HAO LIU 無
- Kun-Huei Yeh 無
- SHIH-HUNG YANG 無
- 郭弘揚 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 高育青 Division of Hematology & Oncology
- Shih-Chang Chuang Division of Gastroenterological Surgery
- Hui-Ching Wang Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳峯旭 無
- CHUNG-HSIN CHANG 無
- Sheng-Shun Yang 無
- 呂宜達 無
- 張碧倚 Division of Radiology
- 蔡炘儒 無
- YI-JU CHEN 無
- YU-HSUAN SHIH 無
- HSIN-CHEN LIN 無
- 陳家昌 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 林昶廷 Division of Hematology & Oncology
- 陳彥仰 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- Yu-Li Su Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
- 常景棣 Division of Radiology
- 陳韻文 Division of Ophthalmology
- Shau-Hsuan Li Division of Hematology & Oncology
- 郭明濬 Division of Hematology & Oncology
- 黃詩喻 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chung-Pin Li Digestive System Department
- Chien-An Liu Division of Radiology
- 黃渝芸 Division of Ophthalmology
- 周昱百 Division of Ophthalmology
- Yi-Ping Hung Division of Hematology & Oncology
- Hung-Yuan Yu Digestive System Department
- 林泰祺 Division of Ophthalmology
- San-Chi Chen Division of Hematology & Oncology
- Pei-Chang Lee Digestive System Department
- 姜乃榕 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
17 participants
-
Global
200 participants